ondasdechoque.org
PT-BR

Patellar tendinopathy · Review · 2026

Does shockwave help jumper's knee, and does the type matter?

In this review of 13 studies, pain scores in the shockwave groups fell from about 5.2 to 2.7, and knee function scores rose from about 55 to 75 where measured. Comparison groups also improved, with pain going from about 4.9 to 3.8. Neither focused nor radial shockwave stood out as better.

Improved over time
studies in the review
13
people whose pain was measured
530
kinds compared: focused and radial
2

Good to know: Studies differed in devices, doses and session numbers, and many people also did exercises.

Friedman A, Spicer S, Garfinkle J, et al. Archives of Rehabilitation Research and Clinical Translation, 2026 · Read the paper ↗

How this study worked

One answer
A review gathers earlier studies to answer one question. Illustration, not to scale.

What the trials used

Focused and radial ESWT protocols
Included trials varied in focused/radial modality, energy flux density, impulses, session number, follow-up and concurrent eccentric exercise. The review discusses this heterogeneity but does not supply one standardized regimen.

Who took part

People with jumper's knee in 13 randomised and non-randomised studies.

Side effects

The review describes shockwave as low-risk but did not count side effects across studies.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Systematic review of focused or radial ESWT for patellar tendinopathy. Thirteen studies (randomized and nonrandomized) included 530 participants for VAS and nine studies/369 participants for VISA.

VAS3 reported outcomes
01
Mean follow-up 12.5 ± 8.1 weeks

Pain (VAS)

VAS Pooled pre/post mean values and standardized effect sizes

Across the ESWT arms (n=372), pooled mean VAS decreased 5.24 to 2.71; control arms (n=158) decreased 4.89 to 3.80. Within-arm Cohen d was −1.54 (95% CI −2.06 to −1.03) for ESWT and −0.48 (−0.76 to −0.20) for control; both p<0.01. The authors report subgroup heterogeneity difference p<0.01 (Q=12.67), but do not provide a pooled between-group change estimate/CI in accessible text.

Analysis details and source

Heterogeneity: control I²=32%; ESWT I²=89%. Across studies, focused/radial protocols and control types differ. This synthesis combines pre/post change and should not be read as an absolute causal effect. Source-reported within-arm Cohen d estimates are structured separately; they are not treatment contrasts. The Methods say all 13 studies reported VAS, but Table 2's Outcomes Measured column lists only VISA for Zwerver et al and Persson Krogh et al; the study and participant counts here are those printed in the text.

04
Baseline to pooled follow-up

Pain (VAS), within ESWT arms

VAS Cohen's d (within-arm pre-post; 95% CI)

Cohen's d (within-arm pre-post)-1.54CI 95% -2.06 to -1.03p <0.01

within-arm baseline-to-follow-up change in ESWT arms; not a between-arm treatment contrast

372 participants in this estimate

-2.3Equal results 00.2

Source-reported within-arm pre/post Cohen's d -1.54 (95% CI -2.06 to -1.03; p <0.01) across 372 participants. This standardized within-arm change is not a causal ESWT-versus-control estimate.

Analysis details and source

Reported separately from pooled group means and the subgroup Q test. No pooled between-group change estimate with CI is supplied in accessible text.

05
Baseline to pooled follow-up

Pain (VAS), within control arms

VAS Cohen's d (within-arm pre-post; 95% CI)

Cohen's d (within-arm pre-post)-0.48CI 95% -0.76 to -0.2p <0.01

within-arm baseline-to-follow-up change in control arms; not a between-arm treatment contrast

158 participants in this estimate

-0.9Equal results 00.1

Source-reported within-arm pre/post Cohen's d -0.48 (95% CI -0.76 to -0.2; p <0.01) across 158 participants. This standardized within-arm change is not a causal ESWT-versus-control estimate.

Analysis details and source

Reported separately from pooled group means and the subgroup Q test. No pooled between-group change estimate with CI is supplied in accessible text.

Victorian Institute of Sport Assessment (VISA)1 reported outcome
02
Mean follow-up 14.53 ± 7.13 weeks

Patellar tendon function (VISA)

Victorian Institute of Sport Assessment (VISA) Pooled pre/post mean values and standardized effect sizes

Across ESWT arms (n=246), pooled mean VISA increased 54.65 to 74.86; controls (n=123) increased 54.90 to 63.16. Within-arm Cohen d was 1.76 (95% CI 0.90–2.62) for ESWT and 0.56 (0.02–1.11) for control; p<0.01 and p=0.04, respectively. Subgroup difference p=0.02 (Q=5.3); no pooled between-group change estimate/CI is provided in accessible text.

Analysis details and source

Heterogeneity: control I²=77%; ESWT I²=94%. Mean follow-up and protocol varied; focused-versus-radial superiority was not established. Source-reported within-arm Cohen d estimates are structured separately; they are not treatment contrasts.

VAS and VISA1 reported outcome
03
Follow-up varied

Focused versus radial ESWT

VAS and VISA Direct comparative narrative

One trial directly randomized focused and radial ESWT, each combined with eccentric training, and found no significant difference in VAS or VISA. Across evidence there was no consistent pattern showing one waveform superior.

Analysis details and source

The review states that the other studies used only one waveform, which prevented a pooled between-waveform comparison. Its own Tables 1 and 2, however, list Şah et al (2023) as a sham-controlled RCT with both a focused and a radial ESWT arm (78 patients); the review reports no focused-versus-radial result from that trial.

VISA2 reported outcomes
06
Baseline to pooled follow-up

Patellar tendon function (VISA), within ESWT arms

VISA Cohen's d (within-arm pre-post; 95% CI)

Cohen's d (within-arm pre-post)1.76CI 95% 0.9 to 2.62p <0.01

within-arm baseline-to-follow-up change in ESWT arms; not a between-arm treatment contrast

246 participants in this estimate

-0.3Equal results 02.9

Source-reported within-arm pre/post Cohen's d 1.76 (95% CI 0.9 to 2.62; p <0.01) across 246 participants. This standardized within-arm change is not a causal ESWT-versus-control estimate.

Analysis details and source

Reported separately from pooled group means and the subgroup Q test. No pooled between-group change estimate with CI is supplied in accessible text.

07
Baseline to pooled follow-up

Patellar tendon function (VISA), within control arms

VISA Cohen's d (within-arm pre-post; 95% CI)

Cohen's d (within-arm pre-post)0.56CI 95% 0.02 to 1.11p = 0.04

within-arm baseline-to-follow-up change in control arms; not a between-arm treatment contrast

123 participants in this estimate

-0.1Equal results 01.2

Source-reported within-arm pre/post Cohen's d 0.56 (95% CI 0.02 to 1.11; p = 0.04) across 123 participants. This standardized within-arm change is not a causal ESWT-versus-control estimate.

Analysis details and source

Reported separately from pooled group means and the subgroup Q test. No pooled between-group change estimate with CI is supplied in accessible text.

How treatment was delivered
Focused and radial ESWT protocols

Included trials varied in focused/radial modality, energy flux density, impulses, session number, follow-up and concurrent eccentric exercise. The review discusses this heterogeneity but does not supply one standardized regimen.

HARMS & TOLERABILITY

The accessible narrative describes ESWT as having a favorable risk profile but does not provide a pooled adverse-event count. Evidence includes nonrandomized studies with moderate/serious risk of bias.

LIMITS OF THE ANALYSIS

High statistical heterogeneity (VAS I²=89%; VISA I²=94% in ESWT arms), variable doses/devices/session counts and concurrent exercise, mixed study designs, and nonrandomized risk of bias. Pooled within-arm changes do not alone establish a causal treatment effect. The article text does not report a pooled between-group estimate with CI, and direct focused-vs-radial evidence is limited to one trial.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • High statistical heterogeneity (VAS I²=89%; VISA I²=94% in ESWT arms), variable doses/devices/session counts and concurrent exercise, mixed study designs, and nonrandomized risk of bias. Pooled within-arm changes do not alone establish a causal treatment effect. The article text does not report a pooled between-group estimate with CI, and direct focused-vs-radial evidence is limited to one trial.
Research review

Source-linked critical reading

Systematic review with meta-analysis

Reading depthMaterial consulted
Technical source record

Read the full article, tables/captions, eligibility, all VAS/VISA pooled results, subgroup/modality narrative, risk-of-bias and GRADE, heterogeneity, limitations and conclusion. Did not infer unreported between-group pooled effects.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic review and meta-analysis searched PubMed, Embase and Web of Science through May 27, 2025. Thirteen studies (mixed RCT and nonrandomized designs) were included.

Participants

Patellar tendinopathy populations across included studies; VAS analyses included 530 participants, VISA analyses 369.

Intervention

Focused and radial ESWT protocols varied in dose, pulses, sessions and eccentric exercise co-care; no single regimen was standardized.

Comparator

Comparators included sham/placebo, PRP, conservative treatment and no control; one trial directly compared focused with radial ESWT.

Outcomes

For VAS, ESWT arms (n=372) changed 5.24 to 2.71; control arms (n=158) 4.89 to 3.80. For VISA, ESWT (n=246) changed 54.65 to 74.86; control (n=123) 54.90 to 63.16. These are pooled pre/post means.

Comparative findings

Within-arm standardized effects favored improvement in both ESWT and controls; subgroup difference tests were reported. Heterogeneity was high in ESWT arms. One direct waveform RCT found no significant focused/radial difference; no consistent superiority pattern emerged.

Harms

No pooled harms count was presented in accessible narrative.

Limitations

VAS/VISA ESWT heterogeneity I² 89%/94%, variable protocols and co-care, mixed study design and observational bias; pooled within-arm changes do not establish causality.

Applicability

Evidence may support ESWT as a treatment option but does not establish optimal modality/dose or superiority over focused/radial comparator.

Research needs

Head-to-head RCTs should standardize waveform, energy, sessions, eccentric exercise, follow-up and harms reporting.

THE ORIGINAL SOURCE

Read the original article.

Systematic Review and Meta-analysis Assessing the Effects of Focal and Radial Extracorporeal Shockwave Therapy on Pain and Function in Patellar Tendinopathy.

Friedman A, Spicer S, Garfinkle J, Tahir H. · Archives of rehabilitation research and clinical translation · 2026

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →